FINANCIAL TRUST COMPANY INC ACCT. W23560001 For the Period 8/1112 to 8/31/12 Note: ** Unrealized Gain/Loss is shown as "N/A" in cases where we do not have appropriate cost information for all tax lots comprising the position Please contact your J P Morgan team for additional information. Equity Detail Price Quantity Value Adjusted Tax Cost Unrealized Gain/Loss Est. Annual Inc. Yield Original Cost Accrued Div. US Large Cap Equity ARIAD PHARMACEUTICALS INC 04033A-10-0 ARIA 20.58 16,535.000 339,959.60 251,475.52 88,484.08 BIOGEN IDEC INC 09062X-10-3 8116 148.59 2,095.000 307,108.05 250,454.95 58,651.10 FACEBOOK INC-A 30303M-10-2 FB 18.06 17,500.000 318,015.00 666,000.00 (348,985.00) GS CONT BUFF ED SPX 719113 80% CONTIN BARRIER- 10.5%CPN 15% CAP INITIAL LEVEL-6/20/12 SPX:1355.69 38143U-Z9-5 102.18 3,000,000.000 3,085,370.00 3,000,000.00 65,370.00 HSBC MARKET PLUS SPX 06117113 72% KO BARRIER- 0%CPN .UNCAPPED INITIAL LEVEL-02/14/12 SPX:1350.50 4042K1-XC1-1 102.68 5,000,000.000 5,134,000.00 5,000,000.00 134,000.00 Total US Large Cap Equity $9.162,450.65 8946030.47 (84,47922) $0.00 0.00% JP Morgan Account W23560001 Page 5 of 36 Consolidated Statement Page 8 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00016212 SDNY_GM_00285410 EFTA01493362